Projected Income Statement: Incyte Corporation

Forecast Balance Sheet: Incyte Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -2,348 -3,239 -3,656 -2,158 -3,098 -5,038 -6,792 -8,670
Change - -37.95% -12.87% 40.97% -43.56% -62.63% -34.82% -27.65%
Announcement Date 08/02/22 07/02/23 13/02/24 10/02/25 10/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Incyte Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 181 77.83 32.49 86.26 58.87 82.27 72.49 70.67
Change - -57% -58.26% 165.54% -31.76% 39.75% -11.88% -2.52%
Free Cash Flow (FCF) 1 568.5 892.1 464 249.1 - 1,325 1,468 1,621
Change - 56.93% -47.99% -46.32% - - 10.77% 10.44%
Announcement Date 08/02/22 07/02/23 13/02/24 10/02/25 10/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Incyte Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 21.55% 17.61% 19.03% 11.86% 33.25% 32.17% 34.92% 31.96%
EBIT Margin (%) 19.62% 17.07% 16.79% 9.76% 31.43% 33.05% 37.67% 40.64%
EBT Margin (%) 19.1% 15.59% 22.57% 7.47% 32.37% 30.56% 32.44% 32.07%
Net margin (%) 31.76% 10.04% 16.17% 0.77% 25.03% 24.49% 25.66% 25.91%
FCF margin (%) 19.04% 26.28% 12.56% 5.87% - 23.57% 23.56% 25%
FCF / Net Income (%) 59.93% 261.88% 77.64% 763.68% - 96.23% 91.82% 96.5%

Profitability

        
ROA 22.34% 6.32% 9.47% 3.72% 22.02% 15.48% 15.15% 13.9%
ROE 29.73% 8.37% 12.5% 5.27% 31.7% 23.72% 22.67% 19.88%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 6.06% 2.29% 0.88% 2.03% 1.14% 1.46% 1.16% 1.09%
CAPEX / EBITDA (%) 28.12% 13.02% 4.62% 17.15% 3.44% 4.55% 3.33% 3.41%
CAPEX / FCF (%) 31.84% 8.72% 7% 34.63% - 6.21% 4.94% 4.36%

Items per share

        
Cash flow per share 1 3.375 4.331 2.198 1.593 7.043 8.803 9.704 9.942
Change - 28.32% -49.26% -27.52% 342.16% 24.99% 10.24% 2.46%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 16.98 19.62 23.14 17.82 26.04 33.74 43.4 53.82
Change - 15.57% 17.94% -22.97% 46.09% 29.58% 28.65% 23.99%
EPS 1 4.27 1.52 2.65 0.15 6.41 6.602 7.581 7.89
Change - -64.4% 74.34% -94.34% 4,173.33% 2.99% 14.83% 4.08%
Nbr of stocks (in thousands) 220,891 222,475 224,109 192,650 196,323 199,782 199,782 199,782
Announcement Date 08/02/22 07/02/23 13/02/24 10/02/25 10/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E ratio 14.4x 12.6x
PBR 2.82x 2.2x
EV / Sales 2.49x 1.97x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
95.31USD
Average target price
108.50USD
Spread / Average Target
+13.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. INCY Stock
  4. Financials Incyte Corporation